Norway Sepsis Diagnostics Market Size & Outlook, 2022-2030
Norway sepsis diagnostics market, 2018-2030 (US$M)
Related Markets
Norway sepsis diagnostics market highlights
- The Norway sepsis diagnostics market generated a revenue of USD 2.8 million in 2022 and is expected to reach USD 4.6 million by 2030.
- The Norway market is expected to grow at a CAGR of 6.4% from 2023 to 2030.
- In terms of segment, blood culture media was the largest revenue generating product in 2022.
- Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.
Sepsis diagnostics market data book summary
| Market revenue in 2022 | USD 2.8 million |
| Market revenue in 2030 | USD 4.6 million |
| Growth rate | 6.4% (CAGR from 2022 to 2030) |
| Largest segment | Blood culture media |
| Fastest growing segment | Assay Kits & Reagents |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
| Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Other key industry trends
- In terms of revenue, Norway accounted for 0.3% of the global sepsis diagnostics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.
Blood culture media was the largest segment with a revenue share of 39.29% in 2022. Horizon Databook has segmented the Norway sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
In Norway, a high-income country renowned for its high life expectancy, national data reveals that sepsis represents a significant challenge within the healthcare system. According to the latest statistics, sepsis accounts for approximately 13% of all hospital deaths.
The mortality rate for patients admitted to hospitals with sepsis is notably high, standing at around 19%. This highlights the critical impact of sepsis on patient outcomes and showcases the need for continued efforts in early diagnosis, effective treatment, and preventive measures to address this severe condition.
Men are more likely to suffer from it than women. Sepsis majorly affects the elderly, and it is expected that as the population ages, the number of sepsis cases will increase in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sepsis Diagnostics Market Scope
Sepsis Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway sepsis diagnostics market size, by product, 2018-2030 (US$M)
Norway Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
